SEC Comment Letter 0000000000-23-003118 to MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099) (MESO)
MESOBLAST LTD (MESO, MEOBF) (CIK 0001345099)
Date: March 28, 2023 · CIK: 0001345099 · Accession: 0000000000-23-003118
AI Filing Summary & Sentiment
File numbers found in text: 333-270814
Letter
United States securities and exchange commission logo March 28, 2023 Silviu Itescu Managing Director and Chief Executive Officer Mesoblast Limited Level 38, 55 Collins Street Melbourne, VIC 3000, Australia Re:Mesoblast Limited Registration Statement on Form F-3 Filed March 24, 2023 File No. 333-270814 Dear Silviu Itescu: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Joshua Gorsky at 202-551-7836 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrew Reilly
Show Raw Text
United States securities and exchange commission logo
March 28, 2023
Silviu Itescu
Managing Director and Chief Executive Officer
Mesoblast Limited
Level 38, 55 Collins Street
Melbourne, VIC 3000, Australia
Re:Mesoblast Limited
Registration Statement on Form F-3
Filed March 24, 2023
File No. 333-270814
Dear Silviu Itescu:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Joshua Gorsky at 202-551-7836 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Andrew Reilly